Related Experiment Video
Updated: May 26, 2026
07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Febrifugine analogue compounds: synthesis and antimalarial evaluation
Shuren Zhu1, Gudise Chandrashekar, Li Meng
1Radix Pharmaceuticals, Inc., 20271 Goldenrod Lane, Suite 2035, Germantown, MD 20876, USA. shuren.zhu@gmail.com
Bioorganic & Medicinal Chemistry
|December 21, 2011
Summary
Novel febrifugine analogues were synthesized to combat malaria. Some analogues show reduced toxicity and potent efficacy against Plasmodium falciparum, offering promising new antimalarial drug candidates.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Pharmacology
Background:
- Febrifugine, an alkaloid from Dichroa febrifuga Lour, is effective against Plasmodium falciparum but has toxic side effects.
- Existing antimalarial drugs also face challenges with toxicity and resistance.
Purpose of the Study:
- To design and synthesize novel febrifugine analogues with improved efficacy and reduced toxicity.
- To evaluate the antimalarial activity and safety profile of these new compounds.
Main Methods:
- Chemical synthesis of febrifugine analogues.
- In vitro and in vivo efficacy testing against Plasmodium falciparum.
- Toxicity assessments and therapeutic window evaluation.
Main Results:
- Several novel febrifugine analogues were successfully synthesized.
- Some analogues demonstrated significantly lower toxicity compared to natural febrifugine and current antimalarials.
- One compound showed high efficacy in Aotus monkeys infected with chloroquine-resistant P. falciparum, with a 50% curative dose of 2mg/kg/day and 100% curative dose of 8 mg/kg/day.
Conclusions:
- The designed febrifugine analogues represent a promising new class of antimalarial agents.
- These compounds possess a favorable balance of efficacy and safety, suggesting wider therapeutic windows.
- The study provides a foundation for the development of next-generation antimalarial drugs.
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...